CYMAT PROVIDES UPDATE ON PRIVATE PLACEMENT FINANCING

Rhea-AI Summary

Cymat Technologies (OTCQB: CYMHF) announced an update to a non-brokered private placement to issue 11,934,615 Units at $0.13 per Unit for gross proceeds of $1,551,500. Each Unit includes one common share and one warrant exercisable at $0.18 for 24 months. No company insiders will participate and no finder's fees or broker warrants will be issued. Proceeds are planned for capital equipment to support a major strategic business development initiative and for working capital. The issuance is subject to TSX Venture Exchange approval and securities will be subject to a four-month hold period.

Positive

• Planned gross proceeds of $1,551,500
• Issuance of 11,934,615 Units at $0.13 per Unit
• Warrants exercisable at $0.18 for 24 months
• No finder's fees or broker warrants to be issued
• Proceeds allocated to capital equipment and working capital

Negative

• Potential shareholder dilution if all warrants are exercised
• Issuance subject to TSX Venture Exchange approval
• Securities subject to a four-month trading hold period
• Exercise could create a new Insider requiring MI 61-101 reliance

MISSISSAUGA, ON, Oct. 21, 2025 /PRNewswire/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat"). Today Cymat provided an update regarding a non-brokered private placement of equity Units (the "Offering"), previously announced on October 2, 2025.

Subject to approval from the TSX Venture Exchange, Cymat intends to issue 11,934,615 equity Units for gross proceeds of $1,551,500. Each Unit will be priced at $0.13 with one Unit consisting of one (1) Common Share and one (1) Common Share Purchase Warrant. Each Warrant will entitle the holder to purchase one Common Share at a price of $0.18 for a twenty-four (24) month period. The Warrants will contain a provision that precludes the Warrant Holders from exercising a number of Warrants that would create a new Insider unless the required submissions are made to, and approvals are received from the TSX Venture Exchange.

No Company Insiders will be participating in this offering. Should the exercise of Warrants ultimately create a new Insider, the Company will rely on an exemption from the formal valuation and minority shareholder approval requirements provided under MI 61-101 pursuant to section 5.5(a) and section 5.7(1)(a) of MI 61-101, on the basis that such Insider Participation would not exceed 25% of the fair market value of the Company's market capitalization. No finder's fees, other related compensation or broker warrants are to be issued in conjunction with this Offering.

Proceeds of the Offering will be used for capital equipment purchases in support of a major strategic business development initiative and for working capital requirements.

In accordance with applicable Canadian securities laws, the securities issued under this Offering will be subject to a four-month trading hold period from the date of their issuance.

The terms of this Offering are subject to approval from the TSX Venture Exchange and closure of this Offering will occur only after said approval is obtained.

About Cymat Technologies Ltd.

Cymat Technologies Ltd. has the global rights, through patents and established know-how, to manufacture and sell Stabilized Aluminum Foam ("SAF"), a unique, ultra-light, cellular metallic material. The proprietary production process entails the injection of gases through a molten bath of alloyed aluminum infused with ceramic particles. The result is an advanced, lightweight, recyclable material that exhibits unique characteristics including customizable density and dimensions; mechanical energy absorption; thermal and acoustic insulation; and time, temperature and strain-rate insensitivity. A key benefit of this continuous foam production process is its scalability and resultant low cost of production. SAF is used in such industries as architectural design, military and automotive. Cymat markets its architectural   SAF under the Alusion^TM brand and its automotive and military SAF under the SmartMetal^TM brand. For further information, please visit our website at www.cymat.com.

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Certain material assumptions regarding such forward-looking statements may be discussed in this news release and the Company's annual and quarterly management's discussion and analysis filed at www.sedar.com. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cymat-provides-update-on-private-placement-financing-302590670.html

SOURCE Cymat Technologies Ltd.

FAQ

What is the size and price of Cymat's CYMHF private placement on October 21, 2025?

Cymat intends to issue 11,934,615 Units at $0.13 per Unit for gross proceeds of $1,551,500.

What are the warrant terms in the CYMHF offering announced October 21, 2025?

Each Unit includes one warrant exercisable for one share at $0.18 for 24 months from issuance.

Will Cymat insiders participate in the CYMHF private placement?

No Company insiders will participate in this offering, per the announcement.

How will Cymat use the proceeds from the CYMHF offering?

Proceeds are planned for capital equipment purchases supporting a major strategic business development initiative and for working capital.

Is the CYMHF private placement final and when will the securities trade?

The offering is subject to TSX Venture Exchange approval and issued securities will be subject to a four-month hold period.

Could warrant exercise create regulatory or insider issues for CYMHF shareholders?

Yes; the company noted warrant exercises that create a new Insider would rely on a MI 61-101 exemption and related approvals.